Smith Group Asset Management’s PTC Therapeutics PTCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-70
| Closed | -$3K | – | 341 |
|
|
2021
Q4 | $3K | Hold |
70
| – | – | ﹤0.01% | 356 |
|
|
2021
Q3 | $3K | Hold |
70
| – | – | ﹤0.01% | 364 |
|
|
2021
Q2 | $3K | Hold |
70
| – | – | ﹤0.01% | 355 |
|
|
2021
Q1 | $3K | Sell |
70
-2,100
| -97% | -$90K | ﹤0.01% | 319 |
|
|
2020
Q4 | $132K | Hold |
2,170
| – | – | 0.01% | 196 |
|
|
2020
Q3 | $101K | Hold |
2,170
| – | – | 0.01% | 198 |
|
|
2020
Q2 | $110K | Sell |
2,170
-30
| -1% | -$1.52K | 0.01% | 189 |
|
|
2020
Q1 | $98K | Hold |
2,200
| – | – | 0.01% | 215 |
|
|
2019
Q4 | $106K | Hold |
2,200
| – | – | ﹤0.01% | 237 |
|
|
2019
Q3 | $74K | Buy |
2,200
+740
| +51% | +$24.9K | ﹤0.01% | 252 |
|
|
2019
Q2 | $66K | Hold |
1,460
| – | – | ﹤0.01% | 260 |
|
|
2019
Q1 | $55K | Sell |
1,460
-3,900
| -73% | -$147K | ﹤0.01% | 296 |
|
|
2018
Q4 | $184K | Buy |
+5,360
| New | +$184K | 0.01% | 249 |
|